M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 13.74 USD 1.85%
Market Cap: 987.9m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of MLTX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MLTX Intrinsic Value
Not Available
Base Case Scenario
Compare MLTX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MLTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MoonLake Immunotherapeutics

Current Assets 411.2m
Cash & Short-Term Investments 380.5m
Receivables 4m
Other Current Assets 26.7m
Non-Current Assets 3.1m
PP&E 2.5m
Other Non-Current Assets 587k
Current Liabilities 48.4m
Accounts Payable 24m
Accrued Liabilities 23.1m
Other Current Liabilities 1.3m
Non-Current Liabilities 77.1m
Long-Term Debt 73.7m
Other Non-Current Liabilities 3.3m
Efficiency

Free Cash Flow Analysis
MoonLake Immunotherapeutics

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
MoonLake Immunotherapeutics

Revenue
0 USD
Operating Expenses
-229.2m USD
Operating Income
-229.2m USD
Other Expenses
18.7m USD
Net Income
-210.5m USD
Fundamental Scores

MLTX Profitability Score
Profitability Due Diligence

MoonLake Immunotherapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
hidden
Profitability
Score

MoonLake Immunotherapeutics's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MLTX Solvency Score
Solvency Due Diligence

MoonLake Immunotherapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
hidden
Solvency
Score

MoonLake Immunotherapeutics's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MLTX Price Targets Summary
MoonLake Immunotherapeutics

Wall Street analysts forecast MLTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLTX is 19.22 USD with a low forecast of 2.02 USD and a high forecast of 89.25 USD.

Lowest
Price Target
2.02 USD
85% Downside
Average
Price Target
19.22 USD
40% Upside
Highest
Price Target
89.25 USD
550% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

MoonLake Immunotherapeutics
does not pay dividends
Shareholder Yield

Current shareholder yield for MLTX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MLTX Insider Trading
Buy and sell transactions by insiders

MLTX News